ADAMO, Marianna
 Distribuzione geografica
Continente #
AS - Asia 6.245
NA - Nord America 6.194
EU - Europa 3.149
SA - Sud America 1.804
AF - Africa 147
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 17.557
Nazione #
US - Stati Uniti d'America 5.970
SG - Singapore 2.400
BR - Brasile 1.556
CN - Cina 1.272
HK - Hong Kong 1.221
IT - Italia 681
DE - Germania 558
VN - Vietnam 480
RU - Federazione Russa 375
GB - Regno Unito 310
FI - Finlandia 307
TR - Turchia 292
UA - Ucraina 195
IE - Irlanda 168
IN - India 144
CA - Canada 112
AR - Argentina 103
BD - Bangladesh 96
FR - Francia 80
MX - Messico 70
PL - Polonia 68
NL - Olanda 67
AT - Austria 61
ZA - Sudafrica 60
CZ - Repubblica Ceca 59
SE - Svezia 58
JP - Giappone 53
IQ - Iraq 51
ES - Italia 48
ID - Indonesia 44
EC - Ecuador 42
SA - Arabia Saudita 30
VE - Venezuela 27
PK - Pakistan 26
BE - Belgio 25
MA - Marocco 25
CO - Colombia 21
UZ - Uzbekistan 19
PY - Paraguay 18
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
KE - Kenya 15
CL - Cile 14
EG - Egitto 13
IL - Israele 12
PE - Perù 11
AU - Australia 10
LT - Lituania 10
TT - Trinidad e Tobago 10
BG - Bulgaria 9
CH - Svizzera 9
HN - Honduras 8
KZ - Kazakistan 8
NP - Nepal 8
AZ - Azerbaigian 7
GR - Grecia 7
IR - Iran 7
KR - Corea 7
LV - Lettonia 7
PH - Filippine 7
UY - Uruguay 7
AL - Albania 5
DZ - Algeria 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
BO - Bolivia 4
EU - Europa 4
MD - Moldavia 4
NO - Norvegia 4
BB - Barbados 3
ET - Etiopia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
AM - Armenia 2
BY - Bielorussia 2
CM - Camerun 2
CY - Cipro 2
DM - Dominica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
PS - Palestinian Territory 2
SI - Slovenia 2
Totale 17.535
Città #
Hong Kong 1.215
Singapore 1.013
Ashburn 625
Beijing 548
Chandler 449
Fairfield 364
Los Angeles 287
New York 277
Istanbul 240
Princeton 238
Helsinki 209
Houston 186
Ho Chi Minh City 185
The Dalles 178
Dublin 168
Woodbridge 165
Seattle 164
Munich 146
Wilmington 142
Moscow 136
São Paulo 133
Cambridge 131
Buffalo 125
Redondo Beach 125
Jacksonville 119
Milan 113
Dallas 108
Chicago 95
Romola 89
Hanoi 83
Shanghai 80
Ann Arbor 73
San Francisco 68
London 55
Warsaw 55
Frankfurt am Main 53
Nuremberg 49
Lappeenranta 46
Tokyo 46
Montreal 45
Rio de Janeiro 45
Turku 45
Brno 44
Brescia 43
Atlanta 41
Brooklyn 41
Rome 36
Boston 34
Poplar 34
Johannesburg 33
Denver 32
Des Moines 32
Belo Horizonte 31
Santa Clara 31
San Diego 30
Toronto 30
Brasília 29
Düsseldorf 29
Stockholm 29
Vienna 28
Chennai 26
Orem 26
Brussels 25
Pune 25
Charlotte 24
Curitiba 24
Phoenix 24
Haiphong 23
Amsterdam 22
Salvador 22
Ankara 19
Brindisi 19
Guangzhou 19
Kyiv 19
Porto Alegre 19
Buenos Aires 18
Changsha 18
Salt Lake City 18
Dhaka 17
Mexico City 17
Nanjing 17
Biên Hòa 16
Tashkent 16
Campinas 15
Da Nang 15
Manchester 15
Prevalle 15
Quito 15
Boardman 14
Erbil 14
Goiânia 14
Kilburn 14
Ribeirão Preto 14
Riyadh 14
Thái Bình 14
Tianjin 14
Washington 14
Baghdad 13
Caxias do Sul 13
Guayaquil 13
Totale 10.036
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 231
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 187
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 183
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 178
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 177
Effectiveness of MitraClip therapy in patients with refractory heart failure 176
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 153
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 148
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 135
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 135
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 118
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 112
September 2019 at a glance: focus on devices 104
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 102
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 102
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 102
January 2020 at a glance: translational medicine, predictors of outcome and treatments 99
Role of nutrition in heart failure patients 98
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 97
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 95
Highlights in heart failure 94
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 94
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 94
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 93
Highlights in valvular heart diseases 91
April 2020 at a glance: epidemiology, prevention, and biomarkers 90
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 90
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 90
December 2019 at a glance: economic burden, co-morbidities, and prognosis 88
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 88
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 87
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 85
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 85
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 85
Transcatheter therapies for tricuspid valve regurgitation 85
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 85
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 84
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 84
[RESHAPE-HF2: new evidence and clinical implications] 83
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 83
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 83
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 82
[Advances in heart failure treatment: a summary of 50 years of evolution] 82
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 81
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 81
2024 update in heart failure 81
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 81
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 79
Percutaneous treatment of mitral regurgitation: looking for a final model 79
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 77
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 77
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 77
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 77
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 75
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 74
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 74
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients 74
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 74
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 73
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 73
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 73
October 2019 at a glance: epidemiology, prevention, and modes of death 73
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 73
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology 72
Il dronedarone: in quali pazienti e con quali associazioni? 72
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 71
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 71
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 70
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 70
[Transcatheter devices for chronic heart failure: state of the art] 70
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 70
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 69
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 69
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 69
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry 68
February 2020 at a glance: acute heart failure and cardio-oncology 68
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 67
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 67
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 67
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 66
July 2020 at a glance: focus on imaging and cardiomyopathies 66
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 65
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatment 65
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 64
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 64
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 64
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry 64
Renal failure after trans-catheter aortic valve implantation 64
OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study 64
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) 63
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 63
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 63
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 63
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 63
Heart failure in the last year: progress and perspective 63
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 63
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 62
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitation 61
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 61
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 60
Totale 8.704
Categoria #
all - tutte 129.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021643 0 0 0 0 0 75 162 102 71 118 71 44
2021/2022728 23 102 22 83 21 57 15 76 34 51 42 202
2022/20231.347 150 48 20 115 101 377 10 144 201 19 85 77
2023/20242.078 111 39 174 150 117 243 144 62 502 79 81 376
2024/20255.393 46 47 185 502 506 433 572 304 440 607 1.067 684
2025/20266.523 1.148 1.557 898 1.730 1.062 128 0 0 0 0 0 0
Totale 17.837